[1] 杨念生,肖海鹏.糖尿病肾病诊治新进展[J]. 新医学,2004,35(2):117-119.
[2] 刘志红,黎磊石.糖尿病肾病发病机理[J]. 中华肾脏病杂志,1999,15(2):120-127.
[3] Fogarty DG, Rich SS, Hanna L, et a1. Urinary albumin excretion in families with type 2 diabetes is heritable and genetically correlated to blood pressure[J]. Kidney Int, 2000, 57(1): 250-257.
[4] 陈宁,郝军,段惠军. 信号通路与糖尿病肾病肾小管细胞外基质沉积[J]. 河北医科大学学报,2018,39(2):231-235.
[5] Kang SW, Adler SG, Lapage J, et al.p38 MAPK and MAPK kinase3/6 mRNA and activities are increased in early diabetic glomeruli[J]. Kidney Int, 2001, 60(2): 543-552.
[6] Polzer K, Soleiman A, Baum W, et al.Selective p38MAPK isoform expression and activation in antineutrophil cytoplasmatic antibody-associated crescentic glomerulonephritis:role of p38MAPKalpha[J]. Ann Rheum Dis, 2008, 67(5): 602-608.
[7] Riad A, Unger D, Du J, et al.Chronic inhibition of p38MAPK improves cardiac and endothelial function in experimental diabetes mellitus[J]. Eur J Pharmacol, 2007, 554(1): 40-45.
[8] Da CJ, Damasceno RS, Machado UF, et al.High glucose concentration stimulates NHE-1 activity in distal nephron cells:the role of the Mek/Erk1/2/p90 and p38MAPK signaling pathways[J].Cell Physiol Biochem, 2014, 33(2): 333-343.
[9] Muller R, Daniel C, Hugo C, et al.The mitogen activated protein kinase p38alpha regulates tubular damage in murine antiglomerular basement membrane nephritis[J]. PLoS One, 2013, 8(2): e56316-e56327.
[10] Fujita H, Omori S, Ishikura K, et al.ERK and p38 mediate high-glucose-induced hypertrophy and TGF-beta expression in renal tubular cells[J]. Am J Physiol Renal Physiol, 2004, 286(1): F120-F126.
[11] Lin CL, Wang JY, Ko JY, et al.Dickkopf-1 promotes hyperglycemia-induced accumulation of mesangial matrix and renal dysfunction[J]. J Am Soc Nephrol, 2010, 21(1): 124-135.
[12] Lin CL, Wang FS, Kuo YR, et al.Ras modulation of superoxide activates ERK dependent fibronectin expression in diabetes induced renal injuries[J]. Kidney Int, 2006, 69(9): 1593-1600.
[13] Wellen KE, Hotamisligil GS.Inflammation, stress, and diabetes[J].J Clin Invest, 2005, 115(5): 1111-1119.
[14] McDonald PH, Chow CW, Miller WE, et al. Beta-arrestin2:a receptor regulated MAPK scaffold for the activation of JNK3[J].Science, 2000, 290(5496): 1574-1577.
[15] Lan HY.Diverse roles of TGF-β/Smads in renal fibrosis and inflammation[J]. Int J Biol Sci, 2011, 7(7): 1056-1067.
[16] Ziyadeh FN, Hoffman BB, Han DC, et al.Longterm prevention of renalin sufficiency, excess matrix gene expression and glomerular mesangial matrix expansion by treatment with monoclonal anti transforming growth factor-beta antibody in db/db diabetic mice[J]. Proc Natl Acad Sci USA, 2000, 97(14): 8015-8020.
[17] Böttinger EP.TGF-beta in renal injury and disease[J]. Semin Nephrol, 2007, 27(3): 309-320.
[18] Sharma K, McGowan TA.TGF-β in diabetic kidney disease: role of novel signaling pathways[J]. Cytokine Growth Factor Rev, 2000, 11(1): 115-123.
[19] 李瑞,郭玉娟,范晴晴,等. NF-κB信号通路在肾间质纤维化发展的作用研究[J]. 药学与临床研究,2018,26(1):43-48.
[20] Jiang Q, Liu P, Wu X, et al.Berberine attenuates lipopolysaccharide induced extracelluar matrix accumulation and inflammation in rat mesangial cells: involvement of NF-κB signaling pathway[J]. Mol Cell Endocrinol, 2011, 331(1): 34-40.
[21] Nusse R, Brown A, Papkoff J, et al.A new nomenclature for int-1 and related genes: the Wnt gene family[J]. Cell, 1991, 64(2): 231.
[22] Ueno K, Hirata H, Hinoda Y,et al.Frizzled homolog proteins, microRNAs and Wnt signaling in cancer[J]. Int J Cancer, 2013, 132(8): 1731-1740.
[23] Surendran K, Schiavi S, Hruska KA.Wnt-dependent beta-Catenin signaling is activated after unilateral ureteral obstruction, and recombinant secreted frizzled-related protein 4 alters the progression of renal fibrosis[J]. J Am Soc Nephrol, 2005, 16(8): 2373-2384.
[24] Niehrs C.The complex world of WNT receptor signalling[J]. Nat Rev Mol Cell Biol, 2012, 13(12): 767-779.
[25] 曹宇,王保兴. JAK/STAT通路在肾脏疾病发病中的作用[J].中华临床医师杂志,2017,1(1):114-118.
[26] Marrero MB, Banes-Berceli AK, Stern DM, et al.Role of the JAK/STAT signaling pathway in diabetic nephropathy[J]. Am J Physiol Renal Physiol, 2006, 290(4): F762-F768.
[27] Berthier CC, Zhang H, Schin M, et al.Enhanced expression of Janus kinase signal transducer and activator of transcription pathway members in human diabetic nephropathy[J]. Diabetes, 2009, 58(2): 469-477.
[28] Amiri F, Shaw S, Wang X, et al.Angiotensin II activation of the JAK/STAT pathway in mesangial cells is altered by high glucose[J]. Kidney Int, 2002, 61(5): 1605-1616.
[29] Beisswenger PJ, Drummond KS, Nelson RG, et al.Susceptibility to diabetic nephropathy is related to dicarbonyl and oxidative stress[J]. Diabetes, 2005, 54(11): 3274-3281.
[30] Wang X, Shaw S, Amiri F, et al.Inhibition of the JAT/STAT signaling pathway prevents the high glucose induced increase in TGF-β and fibronectin synthesis in mesangial cells[J]. Diabetes, 2002, 51(12): 3505-3509.
[31] Mehta D, Rahman A, Malik AB.Protein kinase C-αlpha signals Rho-guanine nucleotide dissociation inhibitor phosphorylation and Rho activation and regulates the endothelial cell barrier function[J].J Biol Chem, 2001, 276(25): 22614-22620.
[32] Axelsson J, Rippe A, Rippe B.Acute hyperglycemia induces rapid, reversible increases in glomerular permeability in nondiabetic rats[J]. Am J Physiol Renal Physiol, 2010, 298(6): F1306-F1312.
[33] Komers R, Oyama TT, Beard DR, et al.Rho kinase inhibition protects kidneys from diabetic nephropathy without reducing blood pressure[J]. Kidney Int, 2011, 79(4): 432-442.
[34] Kikuchi Y, Yamada M, Imakiire T, et al.A Rho-kinase inhibitor, fasudil, prevents development of diabetes and nephropathy in insulinresistant diabetic rats[J]. J Endocrinol, 2007, 192(3): 595-603.
[35] Kolavennu V, Zeng LX, Peng H, et al.Targeting of RhoA/ROCK signaling ameliorates progression of diabetic nephropathy independent of glucose control[J]. Diabete, 2008, 57(3): 714-723. |
